Back to News
Market Impact: 0.15

Detailed Fundamental Analysis

IWDNDAQ
Company FundamentalsDerivatives & VolatilityAnalyst InsightsInvestor Sentiment & Positioning
Detailed Fundamental Analysis

Validea's fundamental report on the iShares Russell 1000 Value ETF (IWD) identifies it as a Large-Cap Low Volatility ETF, scoring highest in Low Volatility (80) and significantly in Value (65), while exhibiting low Momentum (31). The ETF's portfolio is heavily weighted towards the Financial sector and the Biotechnology & Drugs industry, providing a clear factor-based profile for institutional consideration.

Analysis

The iShares Russell 1000 Value ETF (IWD) exhibits a clear factor profile heavily tilted towards defensive characteristics, as detailed in Validea's fundamental report. The ETF scores exceptionally high on Low Volatility at 80 out of 99, reinforcing its classification as a Large-Cap Low Volatility vehicle. This is complemented by a significant value orientation, indicated by a score of 65. In stark contrast, IWD shows a distinct lack of exposure to momentum, scoring a low 31, which suggests its holdings are not comprised of stocks with recent strong price appreciation. The quality factor is neutral with a score of 49. The portfolio's composition is heavily concentrated in the Financial sector, with its largest single industry exposure being Biotechnology & Drugs, a specific allocation that could drive performance independently of broad market value trends.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

IWD0.00
NDAQ0.00

Key Decisions for Investors

  • Investors seeking to de-risk a portfolio or add a core defensive holding should consider IWD, given its high low-volatility score (80) and solid value tilt (65).
  • Be aware that the ETF's very low momentum score of 31 suggests it is likely to underperform the broader market during strong, momentum-driven bull markets.
  • Given the substantial portfolio weight in the Financial and Biotechnology & Drugs sectors, it is crucial to monitor sector-specific catalysts, such as interest rate changes and healthcare policy, as these will heavily influence the ETF's performance.